These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 6105081)

  • 1. Anorectic effect of lisuride and other ergot derivatives in the rat.
    Carruba MO; Ricciardi S; Müller EE; Mantegazza P
    Eur J Pharmacol; 1980 Jun; 64(2-3):133-41. PubMed ID: 6105081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central antidopaminergic properties of 2-bromolisuride, an analogue of the ergot dopamine agonist lisuride.
    Wachtel H; Kehr W; Sauer G
    Life Sci; 1983 Dec; 33(26):2583-97. PubMed ID: 6607392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro selectivity of lisuride and other ergot derivatives for alpha 1- and alpha 2-adrenoceptors.
    McPherson GA
    Eur J Pharmacol; 1984 Jan; 97(1-2):151-5. PubMed ID: 6321208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for a direct dopaminergic effect of lisuride.
    Schechter MD
    Pharmacol Biochem Behav; 1984 Aug; 21(2):185-9. PubMed ID: 6483929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of lisuride on body temperature of rats and rabbits: relation to microsomal biotransformation and dopaminergic receptor stimulation.
    Carruba MO; Ricciardi S; Negreanu J; Calogero M; Mantegazza P
    Psychopharmacology (Berl); 1980; 70(3):223-9. PubMed ID: 6777796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulant properties of bromocriptine on central dopamine receptors in comparison to apomorphine, (+)-amphetamine and L-DOPA.
    Johnson AM; Loew DM; Vigouret JM
    Br J Pharmacol; 1976 Jan; 56(1):59-68. PubMed ID: 943193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of an ergot derivative, lisuride, on the central dopaminergic system -- studies of behavioral pharmacology].
    Hara K; Ikoma Y; Oshino N
    Nihon Yakurigaku Zasshi; 1982 Jul; 80(1):1-13. PubMed ID: 7173731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discriminative stimulus properties of clonidine: substitution by ergot derivatives.
    Cunningham KA; Callahan PM; Craigmyle NA; Appel JB
    Eur J Pharmacol; 1985 Dec; 119(3):225-9. PubMed ID: 2868902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Locomotor effects of lisuride: a consequence of dopaminergic and serotonergic actions.
    Fink H; Morgenstern R
    Psychopharmacology (Berl); 1985; 85(4):464-8. PubMed ID: 2991961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of terguride, an ergot alkaloid derivative, on the central nervous system: biochemical and behavioral studies].
    Ikoma Y; Akai T; Nakata Y; Hara K; Wachtel H; Yamaguchi M
    Nihon Yakurigaku Zasshi; 1993 Aug; 102(2):113-29. PubMed ID: 8370555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoreceptors mediate the inhibition of dopamine synthesis by bromocriptine and lisuride in rats.
    Tissari AH; Rossetti ZL; Meloni M; Frau MI; Gessa GL
    Eur J Pharmacol; 1983 Aug; 91(4):463-8. PubMed ID: 6413231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerance to some behavioural effects of lisuride, a dopamine receptor agonist, and reverse tolerance to others, after repeated administration.
    Carruba MO; Ricciardi S; Chiesara E; Spano PF; Mantegazza P
    Neuropharmacology; 1985 Mar; 24(3):199-206. PubMed ID: 4039419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypothermic action of lisuride in rats and differences to bromocriptine in the antagonistic effect of neuroleptics.
    Horowski R
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Mar; 306(2):147-51. PubMed ID: 36572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the effects of four ergot derivatives on prolactin secretion by dispersed rat pituitary cells.
    Delitala G; Yeo T; Grossman A; Hathway NR; Besser GM
    J Endocrinol; 1980 Oct; 87(1):95-103. PubMed ID: 7430919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of dopaminergic receptors in the behavioral effects induced by lisuride in male rats.
    Baggio G; Ferrari F
    Psychopharmacology (Berl); 1983; 80(1):38-42. PubMed ID: 6408668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoaminergic involvement in the behavioral effects of ergot derivatives.
    Appel JB; Cunningham KA; West KB
    Prog Clin Biol Res; 1985; 192():51-62. PubMed ID: 2867556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Striatal cholinergic function reflects differences in D-2 dopaminergic receptor activation.
    Forloni G; Bidzinski A; Fusi R; Ladinsky H; Consolo S
    Life Sci; 1987 Oct; 41(14):1717-23. PubMed ID: 2958667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioural profile of partial D2 dopamine receptor agonists. 1. Atypical inhibition of d-amphetamine-induced locomotor hyperactivity and stereotypy.
    Clark D; Furmidge LJ; Petry N; Tong ZY; Ericsson M; Johnson D
    Psychopharmacology (Berl); 1991; 105(3):381-92. PubMed ID: 1686815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of lisuride and other ergot derivatives on monoaminergic mechanisms in rat brain.
    Kehr W
    Eur J Pharmacol; 1977 Feb; 41(3):261-73. PubMed ID: 837971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct dopaminergic action of lisuride hydrogen maleate, an ergot derivative, in mice.
    Horowski R; Wachtel H
    Eur J Pharmacol; 1976 Apr; 36(2):373-83. PubMed ID: 945166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.